Search research articles
Contact Us
Filters
Showing results (191-200 of 292) with videos related to
Page
of 30
Sort By:
Seizure
|
February 25, 2016
Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis
Eun-Kee Bae, Jongtae Lee, Jung-Won Shin, et al.
Allergy, Asthma & Immunology Research
|
August 9, 2018
The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs
Heung Woo Park, Sang Heon Kim, Yoon Seok Chang, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
July 16, 2013
Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy
Dong Wook Kim, Namyi Gu, Howard Lee, et al.
Journal of Korean Medical Science
|
January 1, 2019
Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal Impairment
Andrew HyoungJin Kim, Sumin Yoon, Yujin Lee, et al.
Scientific Reports
|
August 10, 2018
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction
Da Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
Basic & Clinical Pharmacology & Toxicology
|
May 9, 2009
Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers
SoJeong Yi, Joo-Youn Cho, Kyoung Soo Lim, et al.
Journal of Proteome Research
|
January 17, 2013
Global metabolomics and targeted steroid profiling reveal that rifampin, a strong human PXR activator, alters endogenous urinary steroid markers
Bora Kim, Ju-Yeon Moon, Man Ho Choi, et al.
Antimicrobial Agents and Chemotherapy
|
March 29, 2017
Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers
Soo Youn Jun, In Jin Jang, Seonghae Yoon, et al.
Drug Metabolism and Pharmacokinetics
|
December 21, 2020
Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjects
Soyoung Lee, Yujin Lee, Andrew HyoungJin Kim, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 22, 2011
Predicting brain occupancy from plasma levels using PET: superiority of combining pharmacokinetics with pharmacodynamics while modeling the relationship
Euitae Kim, Oliver D Howes, Bo-Hyung Kim, et al.
Page
of 30
Search research articles
Search
Showing results (191-200 of 292) with videos related to
Sort By:
Page
of 30
Seizure
|
February 25, 2016
Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis
Eun-Kee Bae, Jongtae Lee, Jung-Won Shin, et al.
Allergy, Asthma & Immunology Research
|
August 9, 2018
The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs
Heung Woo Park, Sang Heon Kim, Yoon Seok Chang, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
July 16, 2013
Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy
Dong Wook Kim, Namyi Gu, Howard Lee, et al.
Journal of Korean Medical Science
|
January 1, 2019
Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal Impairment
Andrew HyoungJin Kim, Sumin Yoon, Yujin Lee, et al.
Scientific Reports
|
August 10, 2018
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction
Da Jung Kim, Seonghae Yoon, Sang Chun Ji, et al.
Basic & Clinical Pharmacology & Toxicology
|
May 9, 2009
Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers
SoJeong Yi, Joo-Youn Cho, Kyoung Soo Lim, et al.
Journal of Proteome Research
|
January 17, 2013
Global metabolomics and targeted steroid profiling reveal that rifampin, a strong human PXR activator, alters endogenous urinary steroid markers
Bora Kim, Ju-Yeon Moon, Man Ho Choi, et al.
Antimicrobial Agents and Chemotherapy
|
March 29, 2017
Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers
Soo Youn Jun, In Jin Jang, Seonghae Yoon, et al.
Drug Metabolism and Pharmacokinetics
|
December 21, 2020
Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjects
Soyoung Lee, Yujin Lee, Andrew HyoungJin Kim, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 22, 2011
Predicting brain occupancy from plasma levels using PET: superiority of combining pharmacokinetics with pharmacodynamics while modeling the relationship
Euitae Kim, Oliver D Howes, Bo-Hyung Kim, et al.
Page
of 30